Intralytix, Inc., founded in 1998, is a biotechnology company specializing in the discovery, production, and marketing of bacteriophage-based products to control bacterial pathogens in environmental, food processing, and medical settings. As a pioneer in bacteriophage technology, Intralytix was the first company globally to receive FDA approval for a phage-based product for food safety applications. The company offers a range of products targeting specific bacterial contaminants, including ListShield™ for Listeria monocytogenes, EcoShield™ PX for Shiga toxin-producing Escherichia coli, and SalmoFresh™ for Salmonella. Intralytix is committed to developing natural, antibiotic-free solutions to address bacterial contamination and antibiotic resistance.